Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older

DSpace/Manakin Repository

Search OPUS

Advanced Search


My Account

Show simple item record

dc.contributor.author Sibbritt, D
dc.contributor.author Adams, J
dc.contributor.author Lui, C-W
dc.contributor.author Broom, A
dc.contributor.author Wardle, J
dc.date.accessioned 2012-10-12T03:33:37Z
dc.date.issued 2012-07-30
dc.identifier.citation PLoS ONE, 2012, 7 (7)
dc.identifier.other C1 en_US
dc.identifier.uri http://hdl.handle.net/10453/18209
dc.description.abstract Objectives: There has been a dramatic increase in the use of complementary medicines over recent decades. Glucosamine is one of the most commonly used complementary medicines in Western societies. An understanding of glucosamine consumption is of significance for public health and future health promotion. This paper, drawing upon the largest dataset to date with regards to glucosamine use (n = 266,844), examines the use and users of glucosamine amongst a sample of older Australians. Design: Analysis of the self-reported data on use of glucosamine, demographics and health status as extracted from the dataset of the 45 and Up Study, which is the largest study of healthy ageing ever undertaken in the Southern Hemisphere involving over 265,000 participants aged 45 and over. Results: Analysis reveals that 58,630 (22.0%) participants reported using glucosamine in the 4 weeks prior to the survey. Use was higher for those who were female, non-smokers, residing in inner/outer regional areas, with higher income and private health insurance. Of all the health conditions examined only osteoarthritis was positively associated with use of glucosamine, while cancer, heart attack or angina and other heart disease were all negatively associated with glucosamine use. Conclusions: This study suggests that a considerable proportion of the Australia population aged 45 and over consume glucosamine. There is a need for health care practitioners to enquire with their patients about their use of glucosamine and for further attention to be directed to providing good quality information for patients and providers with regards to glucosamine products. © 2012 Sibbritt et al.
dc.language eng
dc.relation.isbasedon 10.1371/journal.pone.0041540
dc.title Who uses glucosamine and why? A study of 266,848 Australians aged 45 years and older
dc.type Journal Article
dc.parent PLoS ONE
dc.journal.volume 7
dc.journal.number 7 en_US
dc.publocation USA en_US
dc.identifier.startpage 1 en_US
dc.identifier.endpage en_US
dc.identifier.endpage 6 en_US
dc.cauo.name FOH.Faculty of Health en_US
dc.conference Verified OK en_US
dc.for 1104 Complementary and Alternative Medicine
dc.personcode 115707
dc.personcode 121319
dc.personcode 112076
dc.personcode 114952
dc.percentage 100 en_US
dc.classification.name Complementary and Alternative Medicine en_US
dc.classification.type FOR-08 en_US
dc.edition en_US
dc.custom en_US
dc.date.activity en_US
dc.location.activity en_US
pubs.embargo.period Not known
pubs.organisational-group /University of Technology Sydney
pubs.organisational-group /University of Technology Sydney/Faculty of Health
pubs.organisational-group /University of Technology Sydney/Strength - Health Services and Practice Research
utslib.copyright.status Open Access
utslib.copyright.date 2015-04-15 12:23:47.074767+10
pubs.consider-herdc true
utslib.collection.history General (ID: 2)

Files in this item

This item appears in the following Collection(s)

Show simple item record